1
Clinical Trials associated with Universal CAR T Cells for the Treatment of Acute Myeloid Leukemia
The purpose of this clinical trial is to assess the feasibility, safety and efficacy of universal CAR T-cell products targeting CLL-1, CD33, CD38 and CD123 in patients with relapsed and refractory AML. The study also aims to learn more about the function of the universal CAR T cells and their persistency in AML patients.
100 Clinical Results associated with
100 Translational Medicine associated with
100 Patents (Medical) associated with
100 Deals associated with